A landmark study recently discovered that anemia significantly raises the risk of developing dementia and Alzheimer’s disease in older adults. This condition occurs when the body lacks enough hemoglobin to transport oxygen effectively to various vital organs and brain tissues. Beyond causing chronic fatigue and pale skin, low hemoglobin levels appear to trigger biological changes associated with neurodegeneration.
Researchers from Sweden and Italy monitored 2,282 dementia-free participants over sixty years old living in Stockholm for more than ten years. Every three to six years, scientists measured hemoglobin levels and specific blood biomarkers to observe how health evolved in the group. The data revealed that individuals with anemia at the study’s onset were 66% more likely to develop dementia over time. During the follow-up period of approximately nine years, 362 participants eventually received a clinical dementia diagnosis.
The findings are published in JAMA Network Open.
The Biological Link to Alzheimer’s Disease
Low hemoglobin levels showed a strong correlation with higher levels of blood biomarkers tied specifically to Alzheimer’s disease and brain cell damage. Interestingly, men demonstrated a stronger association between these markers and anemia compared to the female participants in the study.
Analysis: Why “Oxygen Starvation” Damages the Brain
Anemia affects approximately ten percent of people over age 65 and leads to various poor health outcomes globally. One leading explanation suggests that reduced oxygen delivery places sustained stress on brain cells and damages delicate blood vessels. Consequently, this process leads to a gradual loss of neurons and visible brain shrinkage in imaging studies. Anemia may make the brain more vulnerable, causing signs of dementia to appear sooner than in healthy individuals.
Identifying Key Warning Proteins
The researchers utilized data from the Swedish National Study on Aging and Care in Kungsholmen to track these specific pathological links. The highest risks were found in individuals who had both anemia and elevated levels of three critical warning proteins in their blood.
- Phosphorylated tau 217 (p-tau217): A biomarker that builds up during Alzheimer’s-related changes.
- Neurofilament light chain (NfL): A specific marker indicating nerve cell damage.
- Glial fibrillary acidic protein (GFAP): A signal of stress or inflammation within brain cells.
Remarkably, people with both anemia and high NfL levels faced a 3.5-fold higher risk of developing dementia.
Q&A: Understanding the Connection
Q: Can treating anemia prevent the onset of dementia?
A: Researchers suggest anemia is a modifiable risk factor, though further studies must confirm if treatment directly prevents cognitive decline.
Q: Why was the link stronger in men than in women?
A: While the study identified a stronger association in men, the specific biological reasons for this gender difference require further investigation.
FAQ: Common Questions About Anemia and Brain Health
How common is anemia in the elderly population?
Anemia affects roughly one in ten people over the age of 65, making it a widespread health concern.
What are the primary symptoms of anemia?
Common symptoms include persistent fatigue, shortness of breath, and pale skin, though brain impacts are now also suspected.
What proteins are linked to the highest dementia risk?
The study highlights p-tau217, NfL, and GFAP as key biomarkers that signal increased vulnerability when combined with anemia.